scholarly journals Silk fibroin hydrogel as mucosal vaccine carrier: induction of gastric CD4+TRM cells mediated by inflammatory response induces optimal immune protection against Helicobacter felis

2020 ◽  
Vol 9 (1) ◽  
pp. 2289-2302 ◽  
Author(s):  
Chupeng Hu ◽  
Wei Liu ◽  
Ningyin Xu ◽  
An Huang ◽  
Zhenxing Zhang ◽  
...  
2006 ◽  
Vol 55 (7) ◽  
pp. 923-929 ◽  
Author(s):  
Austen Y. Chen ◽  
Scott R. Fry ◽  
Judy Forbes-Faulkner ◽  
Grant Daggard ◽  
T. K. S. Mukkur

The immunogenicity of P97 adhesin repeat region R1 (P97R1) of Mycoplasma hyopneumoniae, an important pathogenesis-associated region of P97, was evaluated in mice as a mucosal vaccine. Mice were immunized orally with attenuated Salmonella typhimurium aroA strain CS332 harbouring a eukaryotic or prokaryotic expression vector encoding P97R1. Local and systemic immune responses were analysed by ELISA on mouse sera, lung washes and splenocyte supernatants following splenocyte stimulation with specific antigens in vitro. Although no P97R1-specific antibody responses were detected in serum and lung washes, significant gamma interferon was produced by P97R1-stimulated splenocytes from mice immunized orally with S. typhimurium aroA harbouring either expression system, indicating induction of a cell-mediated immune response. These results suggested that live bacterial vectors carrying DNA vaccines or expressing heterologous antigens preferentially induce a Th1 response. Surprisingly, however, mice immunized with the vaccine carrier S. typhimurium aroA CS332 induced serum IgG, but not mucosal IgA, against P97R1 or S. typhimurium aroA CS332 whole-cell lysate, emphasizing the importance of assessing the suitability of attenuated S. typhimurium antigen-carrier delivery vectors in the mouse model prior to their evaluation as potential vaccines in the target species, which in this instance was pigs.


2005 ◽  
Vol 133 (2-3) ◽  
pp. 83-91 ◽  
Author(s):  
M. De Bock ◽  
A. Decostere ◽  
K. Van den Bulck ◽  
M. Baele ◽  
L. Duchateau ◽  
...  

2016 ◽  
Vol 19 (4) ◽  
pp. 1015-1018 ◽  
Author(s):  
Kwang Sik Lee ◽  
Bo Yeon Kim ◽  
Doh Hoon Kim ◽  
Byung Rae Jin

Bone ◽  
2012 ◽  
Vol 51 (4) ◽  
pp. 704-713 ◽  
Author(s):  
Yufeng Zhang ◽  
Chengtie Wu ◽  
Tao Luo ◽  
Shue Li ◽  
Xiangrong Cheng ◽  
...  

Gut Pathogens ◽  
2021 ◽  
Vol 13 (1) ◽  
Author(s):  
Chandan Gorain ◽  
Afruja Khan ◽  
Ankita Singh ◽  
Samiran Mondal ◽  
Amirul Islam Mallick

Abstract Background Campylobacter jejuni (C. jejuni) is accountable for more than 400 million cases of gastroenteritis each year and is listed as a high-priority gut pathogen by the World Health Organization (WHO). Although the acute infection of C. jejuni (campylobacteriosis) is commonly treated with macrolides and fluoroquinolones, the emergence of antibiotic resistance among C. jejuni warrants the need for an alternative approach to control campylobacteriosis in humans. To this end, vaccines remain a safe, effective, and widely accepted strategy for controlling emerging and re-emerging infectious diseases. In search of a suitable vaccine against campylobacteriosis, recently, we demonstrated the potential of recombinant Haemolysin co-regulated protein (Hcp) of C. jejuni Type VI secretion system (T6SS) in imparting significant immune-protection against cecal colonization of C. jejuni; however, in the avian model. Since clinical features of human campylobacteriosis are more complicated than the avians, we explored the potential of Hcp as a T6SS targeted vaccine in a murine model as a more reliable and reproducible experimental host to study vaccine-induced immune-protection against C. jejuni. Because C. jejuni primarily utilizes the mucosal route for host pathogenesis, we analyzed the immunogenicity of a mucosally deliverable bioengineered Lactic acid bacteria (LAB), Lactococcus lactis (L. lactis), expressing Hcp. Considering the role of Hcp in both structural (membrane-bound) and functional (effector protein) exhibition of C. jejuni T6SS, a head-to-head comparison of two different forms of recombinant LAB vectors (cell wall anchored and secreted form of Hcp) were tested and assessed for the immune phenotypes of each modality in BALB/c mice. Results We show that regardless of the Hcp protein localization, mucosal delivery of bioengineered LAB vector expressing Hcp induced high-level production of antigen-specific neutralizing antibody (sIgA) in the gut with the potential to reduce the cecal load of C. jejuni in mice. Conclusion Together with the non-commensal nature of L. lactis, short gut transit time in humans, and the ability to express the heterologous protein in the gut, the present study highlights the benefits of bioengineered LAB vectors based mucosal vaccine modality against C. jejuni without the risk of immunotolerance.


2020 ◽  
Vol 6 (8) ◽  
pp. 4573-4582
Author(s):  
Sara Hasanzadeh ◽  
Mehdi Farokhi ◽  
Mehri Habibi ◽  
Mohammad Ali Shokrgozar ◽  
Reza Ahangari Cohan ◽  
...  

2011 ◽  
Vol 175-176 ◽  
pp. 236-241 ◽  
Author(s):  
Hong Jun Yang ◽  
Hai Ye Xu ◽  
Wei Ci Wang ◽  
Chen Xi Ouyang ◽  
Wei Lin Xu

regeneration silk fibroin particles prepared through the dissolving-regeneration route do not fulfill many desired requirements for bio-related applications, due to their partial solubility in water. So, Native silk fibroin powder (NSFP) was prepared by mechanical method to instead of regeneration silk fibroin particles. The goal of this paper is to evaluate the inflammatory response of polyurethane/NSFP composite membrane containing aspirin implanted in mice. The polyurethane/NSFP composite membranes containing aspirin were fabricated by coagulation technique at 30°C. The composite membranes were embedded in mice for 1 weeks and inflammatory response of composite membranes in mice was studied. Inflammatory cells accumulation occurred around implanted polyurethane/NSFP composite membrane, but was reduced significantly in composite membrane containing aspirin. The results indicated that the aspirin released from composite membrane of polyurethane and NSFP could suppress the replication of inflammatory cells and prevent the entering of cells into composite membrane.


2021 ◽  
Vol 12 ◽  
Author(s):  
Lauren J. Johnson ◽  
Siavash Azari ◽  
Amy Webb ◽  
Xiaoli Zhang ◽  
Mikhail A. Gavrilin ◽  
...  

The placenta controls the growth of the fetus and ensures its immune protection. Key to these functions, the syncytiotrophoblast (SYN) is a syncytium formed by fusion of underlying mononuclear trophoblasts. The SYN covers the placental surface and is bathed in maternal blood to mediate nutritional and waste exchanges between the mother and fetus. The bacterial pathogen Listeria monocytogenes breaches the trophoblast barrier and infects the placental/fetal unit resulting in poor pregnancy outcomes. In this work, we analyzed the L. monocytogenes intracellular lifecycle in primary human trophoblasts. In accordance with previous studies, we found that the SYN is 20-fold more resistant to infection compared to mononuclear trophoblasts, forming a protective barrier to infection at the maternal interface. We show for the first time that this is due to a significant reduction in L. monocytogenes uptake by the SYN rather than inhibition of the bacterial intracellular division or motility. We here report the first transcriptomic analysis of L. monocytogenes-infected trophoblasts (RNA sequencing). Pathway analysis showed that infection upregulated TLR2, NOD-like, and cytosolic DNA sensing pathways, as well as downstream pro-inflammatory circuitry (NF-κB, AP-1, IRF4, IRF7) leading to the production of mediators known to elicit the recruitment and activation of maternal leukocytes (IL8, IL6, TNFα, MIP-1). Signature genes associated with poor pregnancy outcomes were also upregulated upon infection. Measuring the release of 54 inflammatory mediators confirmed the transcriptomic data and revealed sustained production of tolerogenic factors (IL-27, IL-10, IL-1RA, TSLP) despite infection. Both the SYN and mononuclear trophoblasts produced cytokines, but surprisingly, some cytokines were predominantly produced by the SYN (IL-8, IL-6) or by non-fused trophoblasts (TNFα). Collectively, our data support that trophoblasts act as placental gatekeepers that limit and detect L. monocytogenes infection resulting in a pro-inflammatory response, which may contribute to the poor pregnancy outcomes if the pathogen persists.


Sign in / Sign up

Export Citation Format

Share Document